ProShare Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-19,203
| Closed | -$99K | – | 1722 |
|
|
2019
Q2 | $99K | Sell |
19,203
-2,354
| -11% | -$12.1K | ﹤0.01% | 1533 |
|
|
2019
Q1 | $78K | Buy |
21,557
+168
| +0.8% | +$608 | ﹤0.01% | 1591 |
|
|
2018
Q4 | $131K | Sell |
21,389
-3,612
| -14% | -$22.1K | ﹤0.01% | 1438 |
|
|
2018
Q3 | $146K | Sell |
25,001
-567
| -2% | -$3.31K | ﹤0.01% | 1642 |
|
|
2018
Q2 | $109K | Buy |
25,568
+397
| +2% | +$1.69K | ﹤0.01% | 1701 |
|
|
2018
Q1 | $111K | Sell |
25,171
-4,139
| -14% | -$18.3K | ﹤0.01% | 1626 |
|
|
2017
Q4 | $154K | Buy |
29,310
+2,303
| +9% | +$12.1K | ﹤0.01% | 1684 |
|
|
2017
Q3 | $166K | Buy |
27,007
+1,685
| +7% | +$10.4K | ﹤0.01% | 1299 |
|
|
2017
Q2 | $183K | Buy |
25,322
+1,709
| +7% | +$12.4K | ﹤0.01% | 1359 |
|
|
2017
Q1 | $125K | Sell |
23,613
-6,217
| -21% | -$32.9K | ﹤0.01% | 1497 |
|
|
2016
Q4 | $214K | Buy |
29,830
+4,203
| +16% | +$30.2K | ﹤0.01% | 1561 |
|
|
2016
Q3 | $240K | Sell |
25,627
-4,765
| -16% | -$44.6K | ﹤0.01% | 1257 |
|
|
2016
Q2 | $192K | Buy |
30,392
+1,038
| +4% | +$6.56K | ﹤0.01% | 1432 |
|
|
2016
Q1 | $162K | Sell |
29,354
-3,114
| -10% | -$17.2K | ﹤0.01% | 1454 |
|
|
2015
Q4 | $181K | Buy |
32,468
+2,970
| +10% | +$16.6K | ﹤0.01% | 1565 |
|
|
2015
Q3 | $250K | Sell |
29,498
-2,136
| -7% | -$18.1K | ﹤0.01% | 1216 |
|
|
2015
Q2 | $478K | Sell |
31,634
-1,873
| -6% | -$28.3K | 0.01% | 1118 |
|
|
2015
Q1 | $536K | Buy |
33,507
+4,357
| +15% | +$69.7K | 0.01% | 1141 |
|
|
2014
Q4 | $519K | Buy |
+29,150
| New | +$519K | 0.01% | 1182 |
|
|
2014
Q3 | – | Sell |
-11,905
| Closed | -$186K | – | 2404 |
|
|
2014
Q2 | $186K | Buy |
+11,905
| New | +$186K | ﹤0.01% | 2204 |
|